Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Am J Clin Pathol. 2011 Jul;136(1):74-80. doi: 10.1309/AJCP9KHD7DCHWLMO.
Melanoma expresses c-kit, a gastrointestinal stromal tumor marker, but has not been extensively evaluated for protein kinase C θ (PKCθ) or DOG1, and these stains have not been correlated with prognostic factors. We immunostained 62 primary cutaneous and 15 metastatic melanomas for polyclonal c-kit (pc-kit), monoclonal c-kit (mc-kit), PKCθ, and DOG1 and correlated results with prognostic parameters and survival. Of the cutaneous melanomas, 34 (55%) stained for pc-kit, 30 (48%) for mc-kit, 11 (18%) for PKCθ, and 2 (3%) for DOG1. The Breslow depth was 1.00 mm or less in 21 (68%) of 31 pc-kit+ cutaneous melanomas compared with 7 (27%) of 26 pc-kit- melanomas (P = .002). The pc-kit+ melanomas had less nodal disease (1/31 [3%] vs 9/25 [36%]; P = .001) and local recurrence (1/33 [3%] vs 6/27 [22%]; P = .021) but no statistically significant difference in the rate of distant metastases (13/32 [41%] vs 14/27 [52%]; P = .388) or survival (10/34 [29%] vs 16/39 [41%]; P = .301). We found that pc-kit correlates better with prognostic parameters than does mc-kit.
黑色素瘤表达 c-kit,这是一种胃肠道间质肿瘤标志物,但尚未广泛评估蛋白激酶 Cθ (PKCθ) 或 DOG1,并且这些染色与预后因素也没有相关性。我们对 62 例原发性皮肤黑色素瘤和 15 例转移性黑色素瘤进行了多克隆 c-kit (pc-kit)、单克隆 c-kit (mc-kit)、PKCθ 和 DOG1 的免疫组织化学染色,并将结果与预后参数和生存情况进行了相关性分析。在皮肤黑色素瘤中,34 例(55%)pc-kit 染色阳性,30 例(48%)mc-kit 染色阳性,11 例(18%)PKCθ 染色阳性,2 例(3%)DOG1 染色阳性。在 31 例 pc-kit+皮肤黑色素瘤中,有 21 例(68%)Breslow 深度为 1.00mm 或更浅,而在 26 例 pc-kit-黑色素瘤中,有 7 例(27%)Breslow 深度为 1.00mm 或更浅(P =.002)。pc-kit+黑色素瘤淋巴结疾病较少(1/31 [3%] vs 9/25 [36%];P =.001),局部复发较少(1/33 [3%] vs 6/27 [22%];P =.021),但远处转移率(13/32 [41%] vs 14/27 [52%])和生存情况(10/34 [29%] vs 16/39 [41%])没有统计学上的显著差异(P =.388;P =.301)。我们发现 pc-kit 与预后参数的相关性优于 mc-kit。